ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 36

The Pleiotropic Effects of TAM Signaling on Inflammatory Arthritis in Mice Using Kbxn Serum Transfer Induced Arthritis

Anna B Montgomery1, Salina Dominguez2, Maximilian Mayr3 and Harris Perlman3, 1Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Department of Medicine Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Northwestern University Feinberg School of Medicine, Chicago, IL

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Apoptosis, Inflammatory arthritis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

TAM receptors are a small family of receptor tyrosine kinases comprising Tyro-3, Axl and Mer, which are activated by GAS6 and Protein-S. TAM signaling is involved in phagocytosis, apoptosis, efferocytosis, and leukocyte stabilization and adhesion, and thus has been implicated in inflammatory disease. In fact, our findings from a previous study show apoptosis of neutrophils in the murine joint during inflammatory arthritis induces polarization of synovial macrophages, a key effector cell in arthritis. These data strongly suggest TAM signaling is involved in inflammatory arthritis in mice. However, TAM signaling can also induce immunoregulatory effects via inhibition of TLR signaling and blockade of the cytokine cascade. To that end, we used a number of genetic mouse models lacking TAM receptors Tyro3, Axl and Mer, or GAS6 to investigate the disparate functionalities of TAM signaling in inflammation using the KBxN model of inflammatory arthritis.

Methods:

Female GAS6-/-, Tyro-3-/-, Mer-/-Axl-/- and C57Bl/6 mice were bred in house until 8-10 weeks of age. Serum transfer induced arthritis was induced in mice using intravenous administration of KBxN sera at a dose of 85µl/20g. Inflammatory arthritis was monitored and scored for severity from day 0-21 or until all mice had 0 clinical score of disease. Clinical score was measured by scoring each distal joint from 0-3 based on inflammation, and summed to give a maximum clinical score of 12 per mouse. Mean clinical scores of N=4 mice in each treatment group were compared using GraphPad Prism. Differences were considered significant if P ≤ 0.05.

Results:

Tyro-3-/- mice developed less severe inflammatory arthritis than C57Bl/6 controls. Mean clinical score in Tyro-3-/- was less than that of C57Bl/6 controls from day 7 until day 14 although this did not reach statistical significance. Both groups had resolved all inflammation by day 21. Mer-/-Axl-/- mice also had reduced mean clinical score compared to C57Bl/6 controls which was statistically significant from day 11-23 (P < 0.05). Inflammation in the Mer-/-Axl-/- group resolved more quickly at day 21 vs day 25. Conversely, the Gas6-/- group had increased disease compared to control mice from day 2 until day 11, which became statistically significant at peak disease on day 7 (P < 0.05).

Conclusion:

These findings demonstrate the pro-inflammatory effects of Tyro-3, Mer and Axl. In these models Tyro3 deletion inhibited early stage disease, whereas Mer Axl deletion resulted in faster disease resolution, thus indicating these receptors induce different downstream effects. Meanwhile, loss of GAS6 in these studies resulted in significantly increased inflammatory arthritis, suggesting GAS6 induces an anti-inflammatory or modulatory effect. Previous studies have shown TAM signaling causes both pro-inflammatory effects and induces a negative feedback loop to reduce inflammation via blockade of TLR signaling. The findings presented here indicate that TAM receptors Tyro-3, Mer and Axl have direct pro-inflammatory functions, whilst specific ligation of GAS6 is required to activate the anti-inflammatory negative feedback process.


Disclosure: A. B. Montgomery, None; S. Dominguez, None; M. Mayr, None; H. Perlman, None.

To cite this abstract in AMA style:

Montgomery AB, Dominguez S, Mayr M, Perlman H. The Pleiotropic Effects of TAM Signaling on Inflammatory Arthritis in Mice Using Kbxn Serum Transfer Induced Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-pleiotropic-effects-of-tam-signaling-on-inflammatory-arthritis-in-mice-using-kbxn-serum-transfer-induced-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-pleiotropic-effects-of-tam-signaling-on-inflammatory-arthritis-in-mice-using-kbxn-serum-transfer-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology